These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28569074)

  • 41. Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.
    Jiang S; Liu J; Chen X; Zheng X; Ruan J; Ye A; Zhang S; Zhang L; Kuang Z; Liu R
    Arch Gynecol Obstet; 2019 Oct; 300(4):829-839. PubMed ID: 31385023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
    Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
    Front Oncol; 2022; 12():962173. PubMed ID: 36059629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
    Zhang F; Gong W
    Front Oncol; 2020; 10():1116. PubMed ID: 32850320
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Onco Targets Ther; 2016; 9():869-76. PubMed ID: 26955285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
    Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis.
    Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    Head Neck; 2018 Dec; 40(12):2714-2723. PubMed ID: 30102821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
    Hu DH; Yu SM
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis.
    Qi X; Chen J; Wei S; Ni J; Song L; Jin C; Yang L; Zhang X
    BMJ Open; 2023 Nov; 13(11):e074874. PubMed ID: 37996220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
    Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
    [No Abstract]   [Full Text] [Related]  

  • 51. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury.
    Zheng CF; Liu WY; Zeng FF; Zheng MH; Shi HY; Zhou Y; Pan JY
    Crit Care; 2017 Sep; 21(1):238. PubMed ID: 28882170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
    Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
    Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
    Ma JY; Ke LC; Liu Q
    Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
    Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
    Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
    World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
    Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
    World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
    Hu G; Liu Q; Ma JY; Liu CY
    Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.